Recent News

Dedicated platform supports day surgery expansion across the UAE and Saudi Arabia. 

Abu Dhabi, 1 October 2026: Burjeel Holdings, a leading super-specialty healthcare services provider in the GCC, has brought its four day surgery centers in the UAE together under a dedicated business vertical, establishing a unified structure to support the next phase of growth in ambulatory and same-day care. As part of the move, Mr. Arun Lobo has been appointed as Chief Executive Officer, Mr. Pawan Sharma as Chief Financial Officer, and Dr. Omer Baldo as Chief Medical Officer of the platform. 

In the UAE, Burjeel currently operates Burjeel Day Surgery Center, Al Reem Island; Burjeel Day Surgery Center, Shahama; Burjeel Day Surgery Center, Al Dhafra; and Burjeel Day Surgery Center, Al Dhahir, Al Ain.  

The move comes as the Group prepares to expand its day surgery footprint. Its current mid-term plan includes four additional centers in the UAE and two in Saudi Arabia, creating a broader regional platform for ambulatory and same-day care. 

Building a Scalable Day Surgery Business 

The four centers will operate under common clinical and operational oversight, with unified financial management and clear accountability for quality, patient experience, growth and financial performance. Burjeel’s day surgery model has demonstrated strong demand and operating efficiency in the UAE, with mature centers delivering EBITDA margins among the highest across the Group’s healthcare assets. The new structure is designed to build on this performance through standardized clinical pathways, better capacity utilization, stronger procurement and workforce planning, and greater visibility over costs and profitability. 

The model also supports more effective allocation of care across Burjeel’s network. Elective and minimally invasive procedures that do not require an overnight stay can be delivered in dedicated same-day settings, releasing theatre and bed capacity at larger hospitals for complex tertiary and quaternary care. This creates the potential to enhance returns on Burjeel’s existing hospital base while adding a high-margin growth engine of its own. 

A Replicable Model for Regional Expansion 

The dedicated platform provides Burjeel with a repeatable operating model for future growth, including greenfield development and partnerships in the UAE and selected GCC markets. New centers can operate within a common framework for clinical quality, financial management, and performance measurement while adapting to local demand and specialty requirements. Developed healthcare markets increasingly deliver elective surgery as day cases, and the UAE’s healthcare agenda is moving decisively in the same direction. With one of the country’s largest dedicated day surgery networks and a clear expansion pipeline, Burjeel is investing to bring this model of care closer to patients. 

Each center will operate as part of Burjeel’s wider network rather than in isolation, drawing on the Group’s hospitals, clinics and consultant base while maintaining access to tertiary and quaternary facilities for patients who require more advanced care. 

The planned day surgery expansion forms part of Burjeel’s broader 18-asset mid-term growth program across multiple healthcare segments in the UAE, Saudi Arabia and the wider GCC, as the Group continues to build specialized healthcare platforms alongside its hospital network. In Saudi Arabia, each Burjeel One day surgery center requires approximately AED 140 million of capex and is expected to generate over AED 200 million in annual revenue at maturity, with a mid-20s EBITDA margin.  

Dedicated Leadership and Accountability 

Commenting on the announcement, Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, said: “Day surgery is not simply an extension of the traditional hospital model. It has its own operating dynamics, capital requirements, and growth potential. Our existing centers have given us a strong foundation in the UAE and bringing them together as one business gives us the structure and accountability to scale the model further. 

As we plan to expand, this platform will allow us to deliver appropriate procedures in a more focused same-day setting while directing the capabilities of our major hospitals toward increasingly complex care. Arun, Pawan and Omer will bring clear operational, financial and clinical leadership to this next phase of growth.” 

As CEO, Mr. Arun Lobo will lead the platform’s strategy, operations, clinical performance and expansion. His appointment expands his responsibilities from his current role as Senior Director – Operations. 

As CFO, Mr. Pawan Sharma will oversee financial strategy, planning, governance, performance management and capital allocation. He currently serves as Cluster Finance Manager. 

As CMO, Dr. Omer Baldo, currently Consultant, Urology, will lead clinical strategy, medical governance, quality outcomes, patient safety and physician engagement across the platform. 

Together, the leadership team will be accountable for growth, profitability, capital efficiency and returns across the platform.

BCI was recently designated by the Department of Health – Abu Dhabi as a Center of Excellence for breast cancer 

Abu Dhabi, 30 September 2026: In line with Breast Cancer Awareness Month, Burjeel Cancer Institute (BCI), one of the largest cancer care networks in the UAE, has launched its Mobile Mammography Truck campaign. The community initiative aims to expand access to early detection services by reaching women at workplaces and communities across the Emirate of Abu Dhabi, including Abu Dhabi City, Al Ain, and surrounding areas. 

The campaign forms part of the efforts of BCI and Burjeel Breast Center to promote a culture of early detection and facilitate access to breast screening services. Supported by the Department of Health – Abu Dhabi (DoH) and Abu Dhabi Public Health Centre (ADPHC), the initiative aligns with ongoing efforts to strengthen breast cancer prevention and early diagnosis across the emirate. 

The Department of Health – Abu Dhabi recently designated Burjeel Cancer Institute as a Center of Excellence for breast cancer, reflecting the Institute’s specialized and integrated approach to breast cancer care. 

Taking Screening to Women 

The Mobile Mammography Truck will travel to dozens of locations across the Emirate of Abu Dhabi, including government and private-sector institutions, schools and educational facilities, shopping malls, residential communities, and several locations in Al Ain. 

It will visit a wide range of organizations and facilities, including Daman, Emirates National Schools, EDGE, Silal, Burjeel Medical Centres in Al Falah and Saadiyat, LLH Hospital in Musaffah, Al Zeina, Al Ain Ladies Club, Al Ain Museum, ADNOC in Al Ain, Raha International School, Yas American Academy, Abu Dhabi Accountability Authority, TAQA Distribution, Etihad Airways’ headquarters in Abu Dhabi and office in Al Ain, Zayed Port, Khalifa Port, KEZAD, Abu Dhabi Maritime Academy, and Reach British School. 

The campaign will also cover public locations and events, including Umm Al Emarat Park, Deerfields Mall, Ghantoot Racing & Polo Club, Al Forsan International Sports Resort, and municipal community facilities across Abu Dhabi City. 

Advanced Screening in a Comfortable Environment 

Equipped with advanced technology, the truck enables women to access breast cancer screening in a safe, comfortable environment that ensures privacy. Mammogram screenings will be conducted under the supervision of a specialized medical and technical team. 

Prof. Humaid Al Shamsi, Chief Executive Officer of Burjeel Cancer Institute, said, “Early detection is one of the most important tools we have in the fight against breast cancer. Through the Mobile Mammography Truck, we aim to bring screening services closer to women, making it easier for them to take that important step toward checking their breast health. Beyond screening, we want to strengthen a culture of prevention and early detection. This complements our strategic vision to increase community awareness and reflects our growing role and social responsibility, particularly following our designation by the Department of Health – Abu Dhabi as a Center of Excellence for breast cancer.” 

The campaign is part of BCI’s comprehensive breast cancer awareness program throughout October. In addition to early detection screenings, it includes community activities and educational sessions led by specialist physicians on risk factors, signs and symptoms, the importance of regular screening, and healthy lifestyle practices. 

An Integrated Breast Cancer Care Model 

At BCI, breast care and awareness extend beyond one month. Through Burjeel Breast Center, a one-stop destination for multidisciplinary, coordinated care, BCI provides integrated breast cancer services that bring together expertise in breast imaging, breast and oncologic surgery, medical oncology, radiation oncology, pathology, nuclear medicine, and reconstructive and plastic surgery, alongside support and follow-up services. The Institute also contributes to medical research and the exchange of scientific expertise. 

The initiative reflects BCI’s ongoing commitment to improving access, raising awareness, and supporting better breast health outcomes across the region.

Advanced imaging technology expands capabilities for complex cardiovascular and image-guided interventions at Burjeel facilities in Abu Dhabi and Sharjah. 

Abu Dhabi, September 25, 2026: Burjeel Holdings, a leading super-specialty healthcare services provider in the GCC, has introduced the GCC’s first-of-its-kind AI-powered Cath Labs at Burjeel Hospital Abu Dhabi and Burjeel Specialty Hospital, Sharjah, expanding its capabilities in complex cardiovascular and image-guided interventions. 

The new facilities feature Siemens Healthineers’ ARTIS icono.vision platform, which combines artificial intelligence, high-definition imaging, advanced 3D visualization, real-time procedural guidance, and automated workflows. The technology gives physicians clearer views of complex anatomy and additional guidance while navigating technically demanding procedures. 

The new Cath Labs expand access to highly specialized, minimally invasive care while giving clinical teams greater capacity to diagnose and treat increasingly complex conditions. The imaging technology is also designed to maintain image quality while helping manage radiation exposure and contrast use, particularly during lengthy or complex interventions. 

Advancing Complex Interventional Care 
Designed as multidisciplinary facilities, the Cath Labs will support teams across Interventional Cardiology, Structural Heart Services, Vascular Surgery, Interventional Radiology, Neurointerventional Procedures, Pain Management, and other specialties that rely on image-guided procedures. 

The technology can support a broad range of procedures, including complex coronary interventions, chronic total occlusion procedures, structural heart interventions, peripheral vascular therapies, embolization procedures, interventional oncology treatments, advanced aortic repairs, and other minimally invasive image-guided interventions. 

A key feature of the platform is OPTIQ AI, which builds on the dynamic adjustment of imaging parameters introduced with the original OPTIQ technology. Its added capability is AI-based analysis of live images, allowing the system to automatically reduce background noise in real time across different 2D imaging modes and body areas. This helps maintain high image quality even at very low radiation doses, supporting the ALARA principle of keeping radiation exposure as low as reasonably achievable while preserving the image quality required for the procedure. 

For patients, these capabilities can support more precise diagnosis and treatment planning, reduce the need for repeat imaging, and provide physicians with better visualization during complex procedures. For clinical teams, clearer imaging and real-time guidance can provide additional support when making decisions during demanding interventions. 

Expanding Capacity and Access 

The new Cath Labs will strengthen interventional capabilities at both Burjeel Hospital Abu Dhabi and Burjeel Specialty Hospital, Sharjah, enabling the facilities to expand access to advanced procedures, manage more complex cases, and support growing demand for specialized cardiovascular and image-guided care. 

At Burjeel Hospital Abu Dhabi, the new facility has doubled Cath Lab capacity, enabling the hospital to handle a higher volume of procedures and meet growing demand for advanced cardiovascular and interventional services. 

The hospital has also recently received AHA Chest Pain accreditation, further strengthening its capabilities in the assessment and management of patients presenting with acute chest pain. 

The new Cath Lab complements Burjeel’s broader cardiovascular program, which covers prevention and early diagnosis, non-invasive and interventional cardiology, coronary angiography, angioplasty and stenting, structural heart interventions, electrophysiology and heart rhythm management, heart failure care, cardiac surgery, rehabilitation, and preventive cardiology. 

Its cardiac surgery services include coronary artery bypass grafting, including off-pump procedures; heart valve repair, replacement and reconstruction; adult congenital heart defect surgery; aortic aneurysm and dissection surgery; complex and redo cardiac surgery; and mechanical circulatory support. 

Dr. Georgie Thomas, Consultant Interventional Cardiologist and Head of Department at Burjeel Hospital Abu Dhabi, said: “In complex interventions, having a clear and accurate view of the anatomy throughout the procedure is critical. The new system gives us enhanced imaging and guidance when navigating challenging cases, while also helping us manage radiation and contrast use. With the additional Cath Lab capacity, we can treat more patients and expand the range of advanced procedures available at the hospital.” 

The platform also provides full 200-degree rotational 3D imaging, flexible ceiling-rail positioning, rapid 3D acquisitions, and system positioning precision of better than 0.5 mm. These capabilities give physicians greater flexibility in obtaining the views they need during complex interventions. 

The new Cath Labs are part of Burjeel’s broader effort to strengthen complex care by bringing together advanced medical technology, multidisciplinary clinical expertise, and comprehensive cardiovascular services across its network. 

Opened in the presence of H.H. Sheikha Dr. Shamma bint Mohammed bin Khalid Al Nahyan, the Trust Fertility & Gynecology Conference 2026 features 85 speakers from 22 countries across 28 scientific sessions and workshops   

Abu Dhabi, September 19, 2026: Abu Dhabi has brought together more than 800 specialists and experts from around the world for the Trust Fertility & Gynecology Conference 2026, one of the region’s major scientific gatherings focused on fertility, reproductive health, obstetrics and gynecology, embryology, and related specialties. 

Held under the theme “Trust in Evidence, Excellence in Practice,” the second edition of the conference opened in the presence of H.H. Sheikha Dr. Shamma bint Mohammed bin Khalid Al Nahyan, Chairperson of the Board of Trustees of the Sheikh Mohammed bin Khalid Al Nahyan Cultural and Educational Institutions, and H.E. Dr. Omniyat Al Hajeri, Executive Director of the Community Health Sector at Abu Dhabi Public Health Centre.  

Organized by Trust Fertility Clinic at Burjeel Medical City, the flagship facility of Burjeel Holdings, the conference is being held with the support and participation of the Department of Health – Abu Dhabi (DoH).  

Featuring 85 speakers from 22 countries, including experts from the United Kingdom, the United States, France, Italy, and Greece, alongside leading Emirati and UAE-based specialists, the conference provides a platform for scientific exchange on the latest evidence, clinical practices, and emerging developments shaping fertility and reproductive healthcare. It also highlights the importance of translating scientific evidence into clinical practice.  

In her opening remarks, H.H. Sheikha Dr. Shamma said: “Scientific gatherings such as this are important because they strengthen the connection between research, medical practice, and society, while creating opportunities for partnerships that can directly improve the quality of life of families. In Abu Dhabi, we have an environment that supports this integration of knowledge, innovation, and compassionate care. Investing in family health is not only an investment in healthcare; it is a long-term investment in people, social stability, and the future.” 

Advancing Evidence-Based Fertility Care 
The scientific program covers a broad range of developments in reproductive medicine, including reproductive endocrinology, fertility preservation, endometriosis-associated infertility, male infertility, embryology, fertility-enhancing surgery, and the evolving relationship between clinical excellence, ethics, and fertility care delivery. 

A key area of focus is fertility-enhancing surgery and the role of advanced surgical techniques in managing conditions that may affect reproductive potential. Experts are discussing developments in laparoscopy and hysteroscopy, including their use in diagnosing and treating conditions linked to infertility and their potential to support improved reproductive outcomes. 

The conference also examines advances in fertility preservation and the options available to individuals who may wish to preserve their reproductive potential for medical or personal reasons. Dedicated sessions explore evolving approaches to endometriosis-related infertility, male reproductive health, embryology, and other areas that can influence fertility outcomes. 

Dr. Walid Reda Sayed, Group Medical Director of Trust Fertility Clinic and Conference Director, said: “This year’s conference brings together leading experts and specialists from around the world to exchange knowledge and clinical experience on developments in fertility and reproductive health. Our scientific program focuses on issues that directly affect the patient journey, from diagnosis and fertility preservation to treatment options and fertility-enhancing surgery. The aim is to support increasingly precise, evidence-based, and personalized approaches to care.” 

Ethics Takes Center Stage 
With reproductive medicine evolving rapidly, the conference includes a dedicated debate on ethics in fertility care, examining the clinical and ethical considerations that accompany new treatments, technologies, and approaches. 

The discussion explores how clinicians can balance scientific progress and evidence-based practice with professional responsibilities, patient interests, and ethical considerations. 

Practical learning is another major component of the conference, with eight specialized workshops covering key areas including laparoscopy, hysteroscopy, and medications used in in-vitro fertilization (IVF) and assisted reproductive treatments. 

Bringing Fertility Awareness to the Community 
Beyond the medical community, this year’s conference also includes a session open to the public, offering insights on fertility, reproductive health, and fertility preservation. 

The session aims to help individuals better understand factors that can influence reproductive health, the options available to them, and the importance of making informed health decisions based on reliable scientific information. 

The conference reflects the UAE’s expanding role as a hub for medical education, research collaboration, and fertility care advancement. 

Projects tackling clinical records, care coordination, referrals, and patient follow-up also recognized 

Abu Dhabi, 11 September 2026: An AI platform designed to help patients understand how urgent their symptoms are and where they should seek care has taken the Gold Prize at the AI Builders Summit 2026 in Abu Dhabi. 

Developed by Hamdan Basheer of 42 Abu Dhabi, PRISM uses conversational AI to assess patient symptoms, determine urgency levels, and guide patients toward the appropriate level of care. The platform also provides clinicians with decision-support insights to enable faster, more informed care. 

PRISM led a group of winning solutions addressing practical gaps across the healthcare journey, from fragmented patient records and care coordination to specialist referrals, follow-up management, and patient understanding. 

The Summit, hosted by AiMed Solutions, the AI and technology arm of Burjeel Holdings, in partnership with Burjeel Training Academy, attracted more than 100 registrations from universities and institutions across the UAE. Nineteen finalists advanced to the Live Demo Day, where their projects were evaluated for clinical relevance, impact, scalability and real-world potential. 

The winners were announced at 42 Abu Dhabi in the presence of Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings; Eng. Abdullah Al Faqeeh, Section Head of IT Operations, Department of Health - Abu Dhabi; and Dr. Hazim Jarrah, Chief of Partnership, Entrepreneurship, and Communications, 42 Abu Dhabi, along with other dignitaries. 

AI Solutions Built Around Healthcare Gaps 

For a patient, PRISM is designed to provide support from the first moment they are unsure about a symptom. Through a conversational interface, patients can describe what they are experiencing and receive an assessment of how urgent the situation may be and what level of care they should consider. The system is designed to help distinguish between cases that may require immediate attention and those that can be directed to an appropriate care setting or provider. 

On the clinical side, PRISM combines patient-reported symptoms with available vital signs and clinical information to highlight possible conditions, red flags, and relevant insights. The aim is not to replace clinical judgment, but to give healthcare professionals structured information that can support faster decision-making. 

“PRISM started from a simple question: how can we help patients understand how urgent their symptoms are and reach the right level of care sooner? This recognition gives us confidence to take the idea further and continue developing it for real healthcare environments,” said Hamdan. 

Bilal Feroz Khan of Al Ain University received the Silver Prize for CaseReady AI, a tool that organizes patient records, identifies missing information and streamlines case preparation for healthcare professionals. 

Khadeja Al Khazraji of Abu Dhabi University received the Bronze Prize for Sanadi AI, a caregiver support platform that connects patients, doctors and caregivers in a shared system to improve care coordination and communication. 

Seven additional category awards highlighted the range of solutions developed during the Summit. Mahadi Hassan of Al Ain University received Best AI Builder for CarePath E-Ink, a hospital journey assistant providing directions, queue updates and multilingual notifications. 

Carolina Sancho Casanova of NYU Abu Dhabi received Best AI for Community Health for CareShield, while Mohammed Sadiq Hussain Shik of Al Ain University was named Rising Star for FAHM, which simplifies complex medical reports for patients. Mohammed F. M. Shaheen of 42 Abu Dhabi received Best Healthcare Innovation for THREAD, which turns radiology follow-up recommendations into tracked actions. Salman Waleed Alshehhi of UAE University received the Most Scalable Concept for CareRoute AI, an AI referral assistant that helps direct patients to the appropriate specialist and tracks referrals through completion. 

Raphael Creer of 42 Abu Dhabi received Best AI Product Thinker for CASCADE, while Milki Teshome Feyera of HCT Dubai received Best UI/UX for Mel’key. 

Taking the Ideas Further 

During the ceremony, Burjeel Holdings announced plans to launch AI Builders Collective, a platform that will bring together the winners and finalists to stay connected, exchange ideas, and explore emerging developments and opportunities in healthcare AI.  

Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, said: “What is encouraging is that these young innovators started with real healthcare problems. They looked at where patients and healthcare professionals face difficulties and built ideas around those needs. We believe strongly in the talent emerging from universities and institutions across the UAE, and we want to support these young innovators as they continue their journey.” 

The AI Builders Summit 2026 forms part of the wider Burjeel 2.0 transformation, with AiMed Solutions advancing technology across clinical care, decision support, patient experience and healthcare operations. 

The hospital’s comprehensive Nuclear Medicine Department, integrated with Burjeel Cancer Institute, offers advanced molecular imaging and expands access to targeted radionuclide therapies 

Sharjah, UAE, September 7, 2026: Burjeel Specialty Hospital, part of Burjeel Holdings, has launched the first PET/CT service in the Emirate of Sharjah, strengthening access to advanced cancer diagnostics and precision treatment closer to patients and families. 

The new service is part of the hospital’s comprehensive Nuclear Medicine Department and is fully integrated with Burjeel Cancer Institute (BCI), the fastest-growing cancer care network in the UAE. The integration connects molecular imaging with multidisciplinary oncology expertise across diagnosis, staging, treatment planning, and follow-up. 

The service was inaugurated in the presence His Excellency Sheikh Faisal bin Khalid bin Sultan Al Qasimi; Dr. Ahmad Tahlak, General Director, Tarahum Charity Foundation; Mohammad Al Mulla, Deputy Director-General, Tarahum Charity Foundation; Dr. Shamsheer Vayalil, Chairman and CEO, Burjeel Holdings; Mr. Abdul Wahab Al Halabi, Non-Executive Director, Burjeel Holdings; Mrs. Aisha Al Mulla, Director of the Friends of Cancer Patients Society. 

Advanced Imaging Closer to Patients 

At the center of the department is the GE Discovery IQ PET/CT system, combining advanced PET detector technology with CT imaging and reconstruction capabilities. It supports cancer diagnosis and staging, treatment-response assessment, recurrence detection, and quantitative imaging. High-sensitivity detector technology enables faster scan acquisition, while lower-dose imaging supports diagnostic performance with reduced radiation exposure. Q-Clear reconstruction further enhances image quality and quantitative accuracy. 

For patients, this means access to advanced molecular imaging services without the need to travel to another emirate. Faster scan times can help reduce the time spent undergoing imaging, while the integrated care model allows results to be reviewed by the wider oncology team, supporting timely and coordinated treatment decisions. The facility operates in line with FANR requirements and internationally recognized radiation safety standards, with patient safety and comfort remaining a key priority. 

“With this capability now available in Sharjah, we can support timely diagnosis, accurate staging and treatment-response assessment while keeping patient safety and comfort at the center of care,” said Dr. Firuz Ibrahim, Head of Department, Nuclear Medicine, Burjeel Specialty Hospital, Sharjah. 

The department offers PET/CT imaging using a broad range of advanced radiotracers. These include 18F FDG PET/CT for staging and treatment-response assessment across many cancers; PSMA PET/CT for prostate cancer; DOTA-peptide PET/CT for neuroendocrine tumors; and specialized tracers supporting evaluation of breast and brain cancers, sarcomas, pancreatic and gastric cancers, parathyroid adenoma, and cognitive impairment. 

Beyond diagnostic imaging, the Sharjah team will collaborate with the BCI Nuclear Medicine team in Abu Dhabi to provide access to targeted radionuclide therapies. These include radioactive iodine therapy for thyroid cancer, peptide receptor radionuclide therapy for neuroendocrine tumors, Lutetium-177 PSMA therapy for advanced prostate cancer, and selective internal radiation therapy for liver cancer and liver metastases. 

“PET/CT is an important tool throughout the cancer journey, from diagnosis and staging to treatment planning, response assessment, and detecting recurrence. Bringing this capability to Sharjah allows us to combine advanced molecular imaging with multidisciplinary cancer expertise so that each patient’s imaging can directly inform a personalized treatment plan,” said Prof. Dr. Humaid Al Shamsi, Chief Executive Officer of Burjeel Cancer Institute. 

The Nuclear Medicine team works closely with BCI specialists across oncology disciplines, creating a seamless pathway from imaging to treatment planning. Diagnostic and therapeutic services are guided by NCCN clinical guidelines and SNMMI/EANM imaging standards, supporting evidence-based, internationally benchmarked care. 

Three-day congress brings together global experts to advance diagnosis, treatment, research, and access to care for rare diseases 

Abu Dhabi, 3 September 2026: The Fifth MENA Congress for Rare Diseases 2026 has opened in Abu Dhabi, bringing together more than 1,500 participants and over 140 speakers specializing in genetic and rare diseases for three days of scientific exchange, collaboration, and discussion on the future of rare disease care and research. The congress is organized in partnership with Burjeel Medical City, Burjeel Cancer Institute, and the Genetics and Rare Disease Center. 

Held with the support and participation of the Department of Health – Abu Dhabi (DoH), the congress opened in the presence of Dr. Asma Al Mannaei, Executive Director of the Health Life Sciences Sector at DoH, and Dr. Mujtaba Ali Khan, CEO of Burjeel Medical City. The event also welcomes 40 international experts from more than 20 countries to discuss the latest developments in the diagnosis, treatment, and research of rare diseases.  

Featuring more than 30 scientific sessions, this year’s congress expands the conversation beyond clinical advances to areas including the health economics of rare diseases, insurance coverage, and medical education. Discussions also cover emerging treatments such as enzyme replacement therapy, advances in diagnostic approaches, and the growing role of scientific research, innovation, and artificial intelligence in supporting the diagnosis and management of genetic and rare diseases. 

The congress is being held alongside the Third MENA Summit for Genetic Counselors, the Fourth MENA Summit for Duchenne Muscular Dystrophy, the Fourth MENA Summit for Angelman Syndrome, and the Fourth MENA Summit for Huntington’s Disease. 

The scientific program highlights advanced therapeutic approaches and technologies, including gene therapy for hemoglobinopathies, hemophilia, Duchenne muscular dystrophy, and spinal muscular atrophy, as well as emerging gene-editing approaches such as CRISPR-Cas9. 

Sessions also explore clinical trials and the development of innovative medicines in the MENA, genomics and multi-omics, and strategies to improve access to advanced therapies. Together, these discussions connect science, clinical practice, and innovation to help shape the next generation of rare disease care. 

Prof. Ayman El-Hattab, Director and Consultant Clinical Genetics at the Genetics and Rare Disease Center, Burjeel Medical City, and President of the Congress, said: “This congress provides a unique platform for specialists and stakeholders in rare diseases to come together, exchange knowledge and expertise, advance research, and identify new opportunities for collaboration. Our goal is to improve care and quality of life for people living with rare diseases in the region and beyond. We are proud to host the congress in Abu Dhabi for the fourth consecutive year, reflecting the capital’s growing role in bringing together the global healthcare and scientific community.” 

Research from Around the World 

The scientific program also features peer-reviewed research abstracts submitted by researchers from around the world. Three winning abstracts, submitted by researchers from Brazil, the United Kingdom, and France, will be recognized and presented during the congress’s scientific sessions. 

Prof. Khaled Musallam, Chairman of the Scientific Committee of the Congress, and Group Chief Research Officer at Burjeel Holdings, said: “The MENA faces a significant burden of rare diseases, and addressing gaps in diagnosis, treatment, and access to care requires collaboration across healthcare, research, industry, and patient communities. Through science, innovation, and stronger partnerships, we can accelerate progress and improve outcomes for people living with rare diseases across the region and beyond.” 

Outstanding Achievement in Rare Diseases Awards 

On the sidelines of the congress, the Awards for Outstanding Achievement in Rare Diseases recognized individuals and organizations that have made significant contributions to advancing the rare disease field. 

In the Clinician category, awards were presented to Dr. Arif Khan, Consultant Pediatric Neurology and Director of the Gene Therapy Program at Fakeeh University Hospital, and Dr. Cristina Skrypnyk, Consultant Medical Genetics, Genetics and Inherited Disorders Department, Al Jawhara Center for Molecular Medicine, Bahrain. 

Dr. Afsheen Raza, Associate Professor and Director of the Abu Dhabi University Cancer Research Institute, received the award in the Researcher category, while Prof. Mahir Al-Hilali, Senior Corporate Director of Laboratory Services at Mediclinic Middle East, was recognized in the Leader category. 

In the Organization category, the award was presented to Chiesi Ltd, a global biopharmaceutical company focused on developing innovative treatments, including therapies for rare diseases. CENTOGENE GmbH, a global diagnostics company headquartered in Germany that supports the diagnosis of patients with rare and genetic diseases, was also recognize

A group of 30 doctors, nurses, clinicians, healthcare leaders, and administrative staff shared stories of leadership, evolving opportunities, and aspirations during the unique Emirati Women’s Day Leadership Journey from Abu Dhabi to Fujairah. 

Abu Dhabi, 27 August 2026: Three generations of Emirati women working across healthcare came aboard Etihad Rail for a unique journey celebrating their achievements, leadership, and contributions to the UAE ahead of Emirati Women’s Day. 

Conceptualized and organized by Burjeel Holdings in collaboration with Etihad Rail, the Emirati Women’s Day Leadership Journey brought together 30 Emirati women for a special journey from Abu Dhabi to Fujairah and back. The participants included senior physicians, doctors, nurses, clinicians, healthcare leaders, and professionals from administrative and support functions, representing different generations and stages of their careers. 

Joining the women on the journey was H.E. Dr. Farida Al Ali, Assistant Undersecretary for National Talent Empowerment at the Ministry of Human Resources and Emiratisation (MoHRE). She shared insights from her leadership journey, highlighting resilience, career development, national contribution, and the growing role of Emirati women in shaping the future of the UAE’s workforce, healthcare sector, and society. 

Three Generations, One Healthcare Journey 

As the train traveled across the UAE, the journey became a setting for conversations about how the professional lives of Emirati women have evolved over the past several decades alongside the development of the country. Senior professionals, mid-career leaders, and younger professionals sat together discussing the evolution of the UAE’s healthcare sector. Women who entered healthcare when career pathways were still expanding exchanged experiences with established leaders shaping healthcare today and younger professionals preparing to take the sector into its next chapter. 

“Healthcare is built by people with very different skills, but with one shared purpose. On this journey, we brought together Emirati doctors, nurses, clinicians, leaders, and colleagues from administrative functions whose careers span different generations. Their stories show how far opportunities for Emirati women have progressed and, more importantly, how every generation is helping create the next set of opportunities. Seeing these conversations take place so naturally across generations was one of the most meaningful aspects of the journey,” said Dr. Tahani Al Qadiri, Associate Vice President - Burjeel Training Academy. 

The program featured leadership conversations, intergenerational discussions, networking, and reflections on resilience, career development, national contribution, and the future role of Emirati women in healthcare and society. 

“When we began our careers, Emirati women were rarely seen in many healthcare specialties. Today, it is inspiring to see the next generation stepping forward with confidence and ambition,” said Dr. Aysha Almahri, CEO - Al Ain Region, Burjeel Holdings. 

Sara Alkatheeri, Nutritionist at Burjeel Medical City (BMC), reflected on how the determination and achievements of the Emirati women who came before her paved the way for the next generation. 

“Today, we have the confidence to dream bigger because the women before us broke barriers and proved what was possible. Their legacy motivates us to keep raising the bar and contribute meaningfully to the future of healthcare in the UAE,” she said.  

The conversations also highlighted the often less-visible roles that keep healthcare systems moving. Alongside doctors and nurses, Emirati women working across administration, operations, patient services, and other functions shared how their work contributes to the delivery of care and the growth of the sector. 

A Journey Reflecting the UAE’s Progress 

The choice of Etihad Rail as the setting added a wider symbolism to the celebration. The journey reflected the broader story of a country that has continuously invested in connecting people, creating opportunities, and building for the future. 

The setting allowed participants to look beyond individual professional milestones and consider how their own journeys have been shaped by the UAE’s development. For each generation, it was an opportunity to reflect on the nation’s changes. 

The Emirati Women’s Day Leadership Journey also created informal opportunities for mentoring and networking, with women from different disciplines and career stages exchanging experiences throughout the journey. As the train returned to Abu Dhabi, one theme echoed across generations: progress is built from one generation to the next. While their experiences differed, each generation spoke of opening doors, creating opportunities, and ensuring those who follow can go further.

More than 1,000 healthcare professionals from 35 nationalities united for 250-sqm installation in Abu Dhabi. 

Abu Dhabi, 22 August 2026: More than 1,000 healthcare professionals from 35 nationalities have come together at Burjeel Medical City (BMC) in Abu Dhabi to create a giant Onam floral carpet (Pookalam) celebrating the UAE’s resilience, unity and continued progress under the leadership of President His Highness Sheikh Mohamed bin Zayed Al Nahyan. 

Spanning 250 sqm, the traditional floral carpet took almost 20 hours to create and features a prominent portrait of H.H. Sheikh Mohamed. It carries the message “The UAE is strong and resilient and emerging stronger,” inspired by words of reassurance from His Highness that offered confidence and hope to the community and became the central thought behind this year’s design. 

The Pookalam interprets resilience through the UAE’s journey from heritage to the future. A visual transition from a traditional camel ride to the Etihad Rail symbolizes the country’s transformation and continued progress, reflecting how strong foundations, long-term vision and determination have enabled the UAE to keep moving forward. 

Other floral elements represent unity and care, highlighting the strength of people coming together, and the importance of healing, recovery, and compassion. The permanent sand pendulum at the center of BMC’s atrium takes on special significance this year as a symbol of time, continuity and forward movement. 

For the healthcare professionals involved, the installation brings together the spirit of Onam with the values they associate with life in the UAE. Onam celebrates renewal, hope, prosperity and togetherness, while this year’s Pookalam reflects how those same values resonate with the country’s ability to face challenges with confidence and emerge stronger. 

Ms. Ameera Al-Katheri, an Emirati national and Assistant Director of Nursing at BMC, said: “Resilience in the UAE comes from the confidence we have in our leadership and in each other. This Pookalam reflects our journey, from the values we inherited to the progress we continue to make together.” 

Dr. Mujtaba Ali Khan, CEO of BMC, said: “This year’s Pookalam is a tribute to the strength and resilience that define the UAE. Bringing together more than 1,000 healthcare professionals from 35 nationalities to create it also reflects the unity and shared sense of belonging that make this country special.” 

Doctors, nurses and other healthcare professionals worked together to complete the floral carpet, reflecting the multicultural character of the UAE’s healthcare workforce and the collaborative spirit behind the annual celebration. 

Dr. Malcolm Borg, a British national and Consultant in Emergency Medicine at BMC, said: “In healthcare, resilience is something we witness every day. It is the ability to recover, adapt, and continue with hope. That is why this year’s theme has a particularly meaningful connection with our work and with the spirit of Onam.” 

Every year, the giant floral carpet at BMC becomes a major attraction of the UAE’s community Onam celebrations, with each edition interpreting the festival through a different national theme connected to the country’s values, priorities and aspirations.

Launched simultaneously at Burjeel Hospital Abu Dhabi and Burjeel Medical City, the integrated framework connects emergency, critical care, and interfacility transfers into a single, coordinated model 

Abu Dhabi, August 11, 2026: Bringing the full strength of its healthcare network together around emergency and acute care patients, Burjeel Holdings has launched BEACON, the Burjeel Emergency and Acute Care Operational Network. Launched simultaneously at Burjeel Hospital Abu Dhabi and Burjeel Medical City, the integrated framework connects emergency, critical care, and interfacility transfers into a single, coordinated model across Abu Dhabi facilities. 

BEACON is designed to ensure that wherever patients first enter the Burjeel network, they can be rapidly connected to the right expertise and the most appropriate level of care. From the initial response and emergency assessment to specialist intervention, critical care, transfer, recovery, and follow-up, the model brings different elements of the patient journey together through shared clinical pathways and coordinated decision-making. 

The launch was marked at an event held at Burjeel Hospital Abu Dhabi, attended by Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings; Mr. Omran Al Khoori, Member of the Board of Directors at Burjeel Holdings; and senior medical professionals from across the Group. 

One Network, One Clinical Standard 

BEACON establishes a common framework for emergency and acute care. Rather than treating the Emergency Department as an isolated point of care, the model connects the patient with the wider capabilities of the network based on clinical need. This includes access to specialist and subspecialist teams, intensive care, diagnostics, inpatient services, and advanced treatment capabilities across the two hospitals. 

The framework is built around four key areas: acute care access, Emergency Department quality and value, integration between the Emergency Department and the wider hospital, and interfacility transfer and prehospital integration. It also strengthens subspecialty routing, standardized clinical protocols, and technology-enabled clinical decision support.   

“When a patient faces an emergency, the strength of our entire healthcare network should be available to them. BEACON brings our people, expertise, infrastructure, and capabilities together around the patient, enabling our teams to respond in a more coordinated and consistent way. Our focus is to connect every patient to the right expertise and level of care when it matters most, while maintaining the highest standards of quality, safety, and patient experience,” said Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings. 

Connecting Care Across the Patient Journey 

By bringing emergency, diagnostic, specialist, and inpatient teams together, BEACON helps reduce unnecessary delays and repeated assessments. Depending on the patient’s condition, emergency physicians can involve specialists in cardiology, neurology, oncology, maternal-fetal medicine, intensive care, surgery, pediatrics, and other disciplines from an early stage in the care process. 

Patients requiring capabilities available at another site can be transferred through coordinated clinical pathways, with the relevant teams involved in decision-making before and during the transfer. This helps patients reach the right specialist care within the Burjeel network more quickly and supports continuity between facilities. 

The model is designed to deliver clinical excellence through experienced teams working to shared standards of care across both hospitals, helping ensure safe, high-quality, and seamless care throughout the patient journey.  

“Emergency care does not begin or end at the doors of the Emergency Department. A patient may need prehospital support, rapid diagnostics, specialist intervention, critical care, or transfer to another facility, often within a very short period of time. BEACON gives our teams a common framework to coordinate these decisions and act as one clinical network. This helps us bring the appropriate expertise to the patient earlier and maintain a consistent standard throughout the care journey,” said Dr. Malcolm Borg, Consultant and Group Head, Emergency Medicine. 

BEACON supports both common emergencies and complex, time-sensitive conditions through standardized pathways across cardiac emergencies, stroke, sepsis, trauma, pediatrics, and acute oncology, while also enabling access to highly specialized and quaternary care across the network. 

Technology support will improve visibility of clinical capacity and specialist availability across participating facilities, helping teams make informed decisions about where patients should receive care. 

The framework also includes the progressive use of clinical decision support and predictive tools to help identify high-risk patients earlier, support acute care navigation, and monitor key quality indicators. Clinician oversight remains central to all technology-enabled decision-making. 

Following its launch at Burjeel Hospital Abu Dhabi and Burjeel Medical City, BEACON will progressively extend across Burjeel’s wider acute care network.  

greement to support integrated healthcare programs, preventive health initiatives, national policy development, and specialized services for priority groups 

Abu Dhabi: The Ministry of Family and Burjeel Holdings have signed a Memorandum of Strategic Partnership to advance family health and quality of life through coordinated, sustainable initiatives. The partnership supports the UAE’s vision of placing the family at the heart of development and social stability and coincides with the Year of the Family. 

The Memorandum was signed by Mr. Omran Al Khoori, Member of the Board of Directors and Chief Business Development Officer at Burjeel Holdings, and Ms. Marwa Al Marzooqi, Acting Assistant Undersecretary for Support Services, Ministry of Family, in the presence of H.E. Sana bint Mohammed Suhail, Minister of Family, and Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings. 

The agreement establishes a framework for integrated healthcare programs, preventive and holistic health initiatives, community awareness, and specialized support for senior citizens, People of Determination, mothers, children, youth, and those preparing for marriage. It will also draw on Burjeel Holdings’ medical and advisory expertise to support national policies related to marriage, fertility, family growth, and sustainability. 

Strengthening Family Health and Stability 

H.E. Sana bint Mohammed Suhail said the Ministry continues to expand partnerships with national institutions, recognizing family stability and quality of life as shared national responsibilities requiring aligned efforts and expertise. She noted that the collaboration will help connect innovative family policies with healthcare services across different stages of life. 

“Through this collaboration, we are focused on launching practical initiatives with sustainable impact across preventive health, mental health, maternal and child health, support for those preparing for marriage and fertility, and healthy aging programs. These efforts will contribute to more integrated services for priority groups, enhance families’ quality of life, and strengthen the family’s pivotal role in raising generations rooted in their values and national identity who contribute effectively to the UAE’s development journey, in line with the ‘We the UAE 2031’ vision,” H.E. Sana Suhail said. 

Dr. Shamsheer Vayalil said: “The health and wellbeing of families are central to building a cohesive, resilient, and prosperous society. We are proud to support the Ministry of Family’s efforts through integrated healthcare programs, preventive health initiatives, and specialized support for different stages of family life. By contributing our medical expertise and capabilities, we aim to support better outcomes for mothers and children, senior citizens, People of Determination, and other priority groups, while advancing the UAE’s vision for healthier families and a stronger, more sustainable society.” 

Integrated Programs and Community Initiatives 

Under the agreement, the two entities will develop preventive and therapeutic healthcare packages through the “Family Wellness” programs and provide healthcare services for Ministry of Family employees and their families. Specialized programs will promote families’ mental and physical wellbeing and support stability and quality of life. 

The partnership will introduce community initiatives for youth, families, and those preparing for marriage, while supporting national programs associated with the Year of the Family. Awareness campaigns, training, and educational workshops will promote reproductive health, mental health, and maternal and child health and encourage positive health behaviors. 

Joint initiatives will include a national model for healthy aging aligned with federal policies; specialized and integrated services for senior citizens and People of Determination; and the “Family Support” program to train and qualify caregivers according to accredited professional standards. The collaboration also covers first aid and emergency response programs and evidence-based technical recommendations to support fertility policies. 

The program will support clinical electives, faculty exchange, joint education, and collaborative research, with training facilitated by Burjeel Training Academy. 

Abu Dhabi, August 04, 2026: Burjeel Cancer Institute at Burjeel Medical City has signed a Memorandum of Understanding with Loyola University Chicago Stritch School of Medicine to advance medical education, clinical training, academic exchange, and collaborative research, with an initial focus on oncology. The agreement developed through exchange visits involving Burjeel Cancer Institute and Loyola University Chicago’s Cardinal Bernardin Cancer Center, during which representatives explored opportunities across cancer education, clinical training, research, and patient care. 

The clinical training program under the agreement will be coordinated and facilitated by Burjeel Training Academy, the medical education and professional development arm of Burjeel Holdings. The agreement represents the Academy’s first academic collaboration with a medical school in the United States. 

Under the MoU, medical students from Stritch School of Medicine will be able to undertake supervised clinical electives and training experiences across Burjeel Holdings’ hospitals and specialty centers in the UAE. 

New Opportunities in Clinical Education and Research 
 
Students will gain exposure to a range of medical and surgical specialties while learning within a healthcare system serving a diverse patient population. The structure and duration of the electives will be determined jointly by the institutions and will be subject to applicable academic and regulatory requirements. 

“This agreement strengthens the academic relationship established between Burjeel Cancer Institute and Cardinal Bernardin Cancer Center. It creates opportunities to advance oncology education and research while enabling students and faculty from both institutions to benefit from shared clinical knowledge and experience,” said Prof. Humaid Al Shamsi, CEO of Burjeel Cancer Institute. 

In addition to student electives, the agreement provides a framework for faculty exchange, joint educational programs, collaborative research, and the development of new clinical learning opportunities. 

“As Burjeel Training Academy’s first collaboration with a US medical school, this partnership reflects confidence in the clinical education and training offered across Burjeel Holdings. We look forward to delivering structured learning opportunities that prepare future physicians to work in diverse and interconnected healthcare environments,” said Dr. Tahani Al Qadiri, Associate Vice President of Burjeel Training Academy. 

Burjeel Training Academy coordinates undergraduate and postgraduate clinical education and professional development programs across Burjeel Holdings. Its programs include observerships, clinical clerkships, medical and dental internships, residency and fellowship training, return-to-practice programs, and continuing medical education and professional development. 

Dr. Theresa Nguyen, Director of the Center for Community and Global Health, Professor of Emergency Medicine, Stritch School of Medicine, said, “The agreement will provide our students with an opportunity to learn in a different healthcare environment and engage with clinicians serving patients from varied cultural and clinical backgrounds. We also look forward to exploring opportunities for faculty collaboration, education, and research with colleagues across Burjeel Cancer Institute and the wider Burjeel network.” 

Founded in 1909, Loyola University Chicago Stritch School of Medicine provides undergraduate, graduate, and continuing medical education, as well as biomedical sciences education and research. Its Health Sciences Campus includes the Cardinal Bernardin Cancer Center, which integrates cancer research, education, and patient care. 

Burjeel Cancer Institute at Burjeel Medical City brings together multidisciplinary expertise across medical, surgical, and radiation oncology, hematology, bone marrow transplantation, precision medicine, and supportive care.